determine the extent and distribution of occupational aetiology. Methods All HP cases identified from a database over a 13 year period were included. The demographic, clinical, exposure history and investigatory Results were reviewed from clinical notes. Cases were categorised in to three groups: occupational, non-occupational and no known cause. Hypothesis testing at the 95% confidence level was used to identify significant differences between the 3 groups. Results A total of 127 cases (13 occupational; 34 non-occupational; 80 no known cause) of HP were identified. Men were more likely to experience occupational HP (p=0.029) compared to the other groups. Occupational HP cases were younger (p=0.002), more likely to experience weight loss (p=0.004), to have systemic symptoms (p=0.007) and a recurrence of symptoms (p<0.001). Occupational HP were due to metal working fluids (MWF), birds, mould/fungi, Farmer's lung, and cleaning and treatment sprays. Non-occupational HP were due to birds, mould/fungi in the home and medication. Percentage lymphocyte count in broncho-alveolar lavage (BAL) was significantly raised in occupational HP (p=0.001). Where no causative agent was identified, there was a greater absence of exposure history (13.2%-32.5%). Conclusion Occupations where there is exposure to birds or those working in trades where industrial processes and the use of chemical compounds predominate, are at risk of occupational HP. Birds remain an important cause of non-occupational HP. Clinical features such as weight loss, systemic symptoms and recurrent symptoms should raise a suspicion of an occupational cause of HP. BAL remains an important investigatory tool in HP, especially in occupational HP. An exposure history, especially an occupational history, is mandatory when assessing suspected cases of HP.
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SHOULD RESPIRATORY HEALTH BE ASSESSED AS PART OF A PRE-SEASON MEDICAL EVALUATION IN PROFESSIONAL FOOTBALLERS?
Introduction and Objectives High rates of exercise induced bronchoconstriction (EIB) are consistently reported in elite endurance athletes, prompting calls to consider screening high risk groups of athletes for respiratory dysfunction. 1 There are currently no robust data examining the prevalence of respiratory symptoms and airway dysfunction (hyper-reactivity and inflammation) in elite footballers. We therefore undertook this prospective study assessing airway health and the impact of treatment in a cohort of professional footballers undergoing squad pre-season screening.
Methods Ninety-seven elite male footballers completed a respiratory assessment including measurement of airway inflammation (FeNO) and screening for EIB using an indirect bronchoprovocation challenge (Eucapnic voluntary hyperpnoea [EVH] ). Players demonstrating a positive challenge result (EVH+) were prescribed appropriate standard asthma therapy directed by EIB severity and underwent repeated assessment after 9 weeks of treatment. Eight players (EVH+=3, EVH-=5) also completed a cardiopulmonary exercise test (VO 2 peak) at the initial and follow-up visits (i.e., post-treatment). Results Twenty-seven players (29%) demonstrated EVH+. Of these, ten (37%) reported no previous history of asthma or EIB. EVH result was not predictable by respiratory symptoms. Seven (24%) of the EVH +players attended for follow-up and demonstrated a reduction in FeNO (pre=85±61 ppb, post=28 ±11 ppb, p=0.04) and a decrease in the fall in FEV 1 post EVH (pre=À22.9±15.4%, post=À9.0±1.6%, p=0.018). At follow-up, VO 2 peak was improved by 3.4±2.9 ml.kg -1 .min -1 in EVH +players compared to 0.1±2.3 ml.kg -1 .min -1 in EVHplayers. Magnitude of inference analysis indicated treatment was possibly beneficial (74%) for exercise capacity. Conclusion Elite footballers have a high EIB prevalence, which remains undetected by a symptom based approach to assessment. Treatment with appropriate standard therapy reduces EIB severity, improves airway inflammation and may improve exercise performance. Therefore, the use of objective tests to screen for EIB in this population would be beneficial.
